Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Richard R, Luce"'
Autor:
Nasir Yusuf, MD, Azhar A Raza, MD, Diana Chang-Blanc, MPH, Bilal Ahmed, MBBS, Tedbabe Hailegebriel, MD, Richard R Luce, MD, Patricia Tanifum, MD, Balcha Masresha, MD, Mehoundo Faton, MD, Mohamed D Omer, MBBS, Saadia Farrukh, MBBS, Khin D Aung, MD, Heather M Scobie, PhD, Rania A Tohme, MD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1610-e1617 (2021)
Summary: This systematic review assessed the progress and barriers towards maternal and neonatal tetanus elimination in the 12 countries that are yet to achieve elimination, globally. Coverage of at least 80% (the coverage level required for eliminat
Externí odkaz:
https://doaj.org/article/8f007e27708e4579ab5ea2f1cb4d5332
Autor:
Garfield R; U.S. Centers for Disease Control and Prevention., Fonjungo P; U.S. Centers for Disease Control and Prevention., Soke G; U.S. Centers for Disease Control and Prevention., Baggett H; U.S. Centers for Disease Control and Prevention., Montgomery J; U.S. Centers for Disease Control and Prevention., Luce R; U.S. Centers for Disease Control and Prevention., Klena J; U.S. Centers for Disease Control and Prevention., Mbala-Kingebeni P; Institut National de Recherche Biomédicale, MOH, Democratic Republic of the Congo., Ahuka S; Institut National de Recherche Biomédicale, MOH, Democratic Republic of the Congo., Mwamba D; National Public Health Institute, MOH, Democratic Republic of the Congo., Muyembe-Tamfam JJ; Institut National de Recherche Biomédicale, MOH, Democratic Republic of the Congo., Agolory S; U.S. Centers for Disease Control and Prevention.
Publikováno v:
Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2024 Nov 22; Vol. 18, pp. e287. Date of Electronic Publication: 2024 Nov 22.
Autor:
Soke GN; Division for Global Health Protection, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA. yxo2@cdc.gov., Fonjungo P; Division for Global HIV and Tuberculosis, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mbuyi G; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Luce R; Division for Global Health Protection, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA., Klena J; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Choi M; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kombe J; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Makaya G; Vysnova partners, Landover, MD, USA., Mbuyi F; Vysnova partners, Landover, MD, USA., Bulambo H; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mossoko M; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Mwanzembe C; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Ikomo B; Equateur Provincial Division of Health. Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Adikey P; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Montgomery J; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Shoemaker T; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mbala P; National Institute for Biomedical Research, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Earle-Richardson G; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mwamba D; Directorate of Disease Control, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo., Tamfum JM; National Institute for Biomedical Research, Democratic Republic of the Congo Ministry of Health, Prevention and Hygiene, Kinshasa, Democratic Republic of the Congo.
Publikováno v:
Global health, science and practice [Glob Health Sci Pract] 2024 Aug 27; Vol. 12 (4). Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).
Autor:
McQuiston JH, Luce R, Kazadi DM, Bwangandu CN, Mbala-Kingebeni P, Anderson M, Prasher JM, Williams IT, Phan A, Shelus V, Bratcher A, Soke GN, Fonjungo PN, Kabamba J, McCollum AM, Perry R, Rao AK, Doty J, Christensen B, Fuller JA, Baird N, Chaitram J, Brown CK, Kirby AE, Fitter D, Folster JM, Dualeh M, Hartman R, Bart SM, Hughes CM, Nakazawa Y, Sims E, Christie A, Hutson CL
Publikováno v:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 May 16; Vol. 73 (19), pp. 435-440. Date of Electronic Publication: 2024 May 16.
Autor:
Kallay R; Division of Global Health Protection, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA, 30329, USA. qcp9@cdc.gov., Mbuyi G; National Epidemiology Surveillance Direction, DRC Ministry of Health, Hygiene and Prevention Kinshasa, Kinshasa, Democratic Republic of the Congo., Eggers C; Division of Global Health Protection, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA, 30329, USA., Coulibaly S; Division of Global Health Protection, Centers for Disease Control and Prevention, Bizzell US, Kinshasa, Democratic Republic of the Congo., Kangoye DT; Division of Global Health Protection, Centers for Disease Control and Prevention, Bizzell US, Kinshasa, Democratic Republic of the Congo., Kubuya J; North Kivu Provincial Health Direction, DRC Ministry of Health, Hygiene and Prevention, Goma, Democratic Republic of the Congo., Soke GN; Division of Global Health Protection, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo., Mossoko M; National Epidemiology Surveillance Direction, DRC Ministry of Health, Hygiene and Prevention Kinshasa, Kinshasa, Democratic Republic of the Congo., Kazambu D; African Field Epidemiology Network, Kinshasa, Democratic Republic of the Congo., Magazani A; African Field Epidemiology Network, Kinshasa, Democratic Republic of the Congo., Fonjungo P; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo., Luce R; Division of Global Health Protection, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo., Aruna A; National Epidemiology Surveillance Direction, DRC Ministry of Health, Hygiene and Prevention Kinshasa, Kinshasa, Democratic Republic of the Congo.
Publikováno v:
BMC public health [BMC Public Health] 2024 Apr 24; Vol. 24 (1), pp. 1150. Date of Electronic Publication: 2024 Apr 24.
Autor:
Dixon MG; Global Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: mgdixon@cdc.gov., Tapia MD; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA., Wannemuehler K; Global Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Department of Biostatistics & Medical Informatics, University of Wisconsin - Madison, WI, USA., Luce R; Expanded Program on Immunization, WHO Regional Office for Africa, Inter-Country Support Team for West Africa, Ouagadougou, Burkina Faso., Papania M; Global Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Sow S; Center for Vaccine Development, Ministry of Health, Bamako, Mali., Levine MM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA., Pasetti MF; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mpasetti@som.umaryland.edu.
Publikováno v:
Vaccine [Vaccine] 2022 Feb 23; Vol. 40 (9), pp. 1316-1322. Date of Electronic Publication: 2022 Jan 31.
Autor:
Nomhwange T; World Health Organization, Country Office, Abuja, Nigeria., Mohammed A; World Health Organization, Borno State Office, Maiduguri, Nigeria., Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria., Musa A; World Health Organization, Borno State Office, Maiduguri, Nigeria., Yusuf A; World Health Organization, Borno State Office, Maiduguri, Nigeria., Yusuf M; World Health Organization, Borno State Office, Maiduguri, Nigeria., Wagai J; World Health Organization, Country Office, Abuja, Nigeria., Shettima A; State Primary Health Care Development Agency, Borno State, Nigeria., Meleh S; World Health Organization, Inter-country Support Team for West Africa, Ouagadougou, Burkina Faso., Banda R; World Health Organization, Country Office, Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Luce R; State Primary Health Care Development Agency, Borno State, Nigeria., Masresha B; World Health Organization, Inter-country Support Team for West Africa, Ouagadougou, Burkina Faso.
Publikováno v:
The Pan African medical journal [Pan Afr Med J] 2022 Feb 06; Vol. 41, pp. 104. Date of Electronic Publication: 2022 Feb 06 (Print Publication: 2022).
Autor:
Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria. Electronic address: jeana@who.int., Masresha B; World Health Organization, African Regional Office, Brazzaville, Congo., Wagai J; World Health Organization, Country Office, Abuja, Nigeria., Luce R; World Health Organization, Inter-country Support Team for West Africa, Ouagadougou, Burkina Faso., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations, Nigeria., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Ikeonu OC; World Health Organization, Country Office, Abuja, Nigeria., Chukwuji M; World Health Organization, Country Office, Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Sanders EAM; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands., Hahné S; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands., Hak E; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C89-C95. Date of Electronic Publication: 2021 Apr 17.
Autor:
Masresha B; World Health Organisation, Regional Office for Africa, Brazzaville, Congo., Luce R; World Health Organisation, Inter-Country Support Team for Western Africa, Ouagadougou, Burkina Faso., Katsande R; World Health Organisation, Regional Office for Africa, Brazzaville, Congo., Dosseh A; World Health Organisation, Inter-Country Support Team for Western Africa, Ouagadougou, Burkina Faso., Tanifum P; World Health Organisation, Inter-Country Support Team for Central Africa, Libreville, Gabon., Lebo E; World Health Organisation, Inter-Country Support Team for East and Southern Africa, Harare, Zimbabwe., Byabamazima C; World Health Organisation, Inter-Country Support Team for East and Southern Africa, Harare, Zimbabwe., Kfutwah A; World Health Organisation, Inter-Country Support Team for Central Africa, Libreville, Gabon.
Publikováno v:
The Pan African medical journal [Pan Afr Med J] 2021 Jul 08; Vol. 39, pp. 192. Date of Electronic Publication: 2021 Jul 08 (Print Publication: 2021).
Autor:
Jean Baptiste AE; World Health Organization (WHO), Country Office, Abuja, Nigeria. jeana@who.int., Wagai J; World Health Organization (WHO), Country Office, Abuja, Nigeria., Luce R; World Health Organization (WHO), Inter-country Support Team for West Africa, Ouagadougou, Burkina Faso., Masresha B; World Health Organization (WHO), African Regional Office, Brazzaville, Congo., Klinkenberg D; National Institute for Public Health and The Environment, Bilthoven, Netherlands., Veldhuijzen I; National Institute for Public Health and The Environment, Bilthoven, Netherlands., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations, Abuja, Nigeria., Ikeonu OC; World Health Organization (WHO), Country Office, Abuja, Nigeria., Meleh S; State Primary Health Care Development Agency, Maiduguri, Borno State, Nigeria., Musa A; World Health Organization (WHO), Country Office, Abuja, Nigeria., Braka F; World Health Organization (WHO), Country Office, Abuja, Nigeria., Hahné S; National Institute for Public Health and The Environment, Bilthoven, Netherlands., Sanders EAM; National Institute for Public Health and The Environment, Bilthoven, Netherlands., Hak E; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Publikováno v:
BMC public health [BMC Public Health] 2021 Mar 04; Vol. 21 (1), pp. 437. Date of Electronic Publication: 2021 Mar 04.